Pharmacokinetics of mirtazapine and effect on plasma levels of bioactive peptides in healthy japanese.

Pharmacokinetics of mirtazapine and effect on plasma levels of bioactive peptides in healthy japanese. - Pharmacokinetics of mirtazapine and effect on plasma levels of bioactive peptides in healthy japanese.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000007391

Enrollment

Registered

2012-02-28

Start date

2011-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

healthy volunteers

Interventions

1) placebo 2) mirtazapine 1) mirtazapine 2) placebo

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: written informed consent before the study volunteers ascertained to be healthy by a medical history, a physical examination

Exclusion criteria

Exclusion criteria: smokers pregnant women nursing women

Design outcomes

Primary

Measure	Time frame
Plasma level of mirtazapine, ACTH, NPY. cortisol	—

Countries

Japan

Contacts

Public ContactYosuke Suzuki

Oita University Hospital Department of Clinical Pharmacy

y-suzuki@oita-u.ac.jp097-586-6113

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026